159 related articles for article (PubMed ID: 27387674)
41. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
42. Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. A comparison between first episode and recurrent infection.
Sakran W; Smolkin V; Odetalla A; Halevy R; Koren A
Clin Pediatr (Phila); 2015 May; 54(5):479-83. PubMed ID: 25385933
[TBL] [Abstract][Full Text] [Related]
43. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
44. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
Ratjen F; Döring G; Nikolaizik WH
Lancet; 2001 Sep; 358(9286):983-4. PubMed ID: 11583754
[TBL] [Abstract][Full Text] [Related]
45. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
46. Microbiological and clinical aspects of aspiration pneumonia.
Lode H
J Antimicrob Chemother; 1988 Apr; 21 Suppl C():83-90. PubMed ID: 3290185
[TBL] [Abstract][Full Text] [Related]
47. [Evaluation of antibiotic resistance in material isolated from the middle ear in children with acute otitis media not responding to standard antibiotic treatment].
Zielnik-Jurkiewicz B; Bielicka A
Otolaryngol Pol; 2007; 61(5):892-7. PubMed ID: 18552043
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of Stenotrophomonas maltophilia bacteremia in children.
Furuichi M; Ito K; Miyairi I
Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling.
George DL; Falk PS; Wunderink RG; Leeper KV; Meduri GU; Steere EL; Corbett CE; Mayhall CG
Am J Respir Crit Care Med; 1998 Dec; 158(6):1839-47. PubMed ID: 9847276
[TBL] [Abstract][Full Text] [Related]
50. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
[TBL] [Abstract][Full Text] [Related]
51. Acid aspiration induces bacterial pneumonia by enhanced bacterial adherence in mice.
Mitsushima H; Oishi K; Nagao T; Ichinose A; Senba M; Iwasaki T; Nagatake T
Microb Pathog; 2002 Nov; 33(5):203-10. PubMed ID: 12473435
[TBL] [Abstract][Full Text] [Related]
52. Respiratory secretion analyses in the evaluation of ventilator-associated pneumonia: a survey of current practice in pediatric critical care.
Willson DF; Kirby A; Kicker JS
Pediatr Crit Care Med; 2014 Oct; 15(8):715-9. PubMed ID: 25068248
[TBL] [Abstract][Full Text] [Related]
53. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
[TBL] [Abstract][Full Text] [Related]
54. Treatment strategy for older patients with pneumonia independent of the risk of drug resistance in the world's top country for longevity.
Komiya K; Yamatani I; Kadota JI
Respir Investig; 2024 Jul; 62(4):710-716. PubMed ID: 38823190
[TBL] [Abstract][Full Text] [Related]
55. Can early bacterial complications of aspiration with respiratory failure be predicted?
Kennedy GA; Kanter RK; Weiner LB; Tompkins JM
Pediatr Emerg Care; 1992 Jun; 8(3):123-5. PubMed ID: 1377384
[TBL] [Abstract][Full Text] [Related]
56. Bacteriology and treatment of gram-negative pneumonia in long-term hospitalized children.
Brook I
Chest; 1981 Apr; 79(4):432-7. PubMed ID: 7226908
[TBL] [Abstract][Full Text] [Related]
57. [Bacteriologic monitoring of bronchial secretions in surgical intensive care].
Duez JM; Freysz M; Kohli E; Minello C; Wilkening M; Kazmierczak A
Pathol Biol (Paris); 1985 May; 33(5):440-3. PubMed ID: 3929220
[TBL] [Abstract][Full Text] [Related]
58. Bacteriological testing and recurrence prevention efforts in the diagnosis and treatment of nursing- and healthcare-associated pneumonia and aspiration pneumonia: A questionnaire survey of hospitals across Japan.
Kenzaka T; Kumabe A; Kosami K; Matsuoka Y; Minami K; Ninomiya D; Noda A; Yahata S
Respir Investig; 2018 Mar; 56(2):150-157. PubMed ID: 29548653
[TBL] [Abstract][Full Text] [Related]
59. Clindamycin in treatment of aspiration pneumonia in children.
Brook I
Antimicrob Agents Chemother; 1979 Mar; 15(3):342-5. PubMed ID: 380459
[TBL] [Abstract][Full Text] [Related]
60. Significance of Pseudomonas aeruginosa colonization of the gastrointestinal tract.
Ohara T; Itoh K
Intern Med; 2003 Nov; 42(11):1072-6. PubMed ID: 14686744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
